Humana (HUM) Current Deferred Revenue (2009 - 2026)

Humana's Current Deferred Revenue history runs 18 years deep, the most recent figure standing at $269.0 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue rose 1.51% year-over-year to $269.0 million; the TTM figure through Mar 2026 stood at $269.0 million (up 1.51% YoY), while the FY2025 annual figure was $356.0 million, up 36.92% from the prior year.
• Current Deferred Revenue was $269.0 million for Q1 2026 at Humana, down from $356.0 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $7.5 billion in Q3 2023 to a low of $195.0 million in Q3 2024.
• Historically, Current Deferred Revenue has averaged $1.9 billion across 5 years, with a median of $286.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue soared 2694.7% in 2023, then sank 97.41% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $286.0 million in 2022, then retreated by 6.99% to $266.0 million in 2023, then slipped by 2.26% to $260.0 million in 2024, then surged by 36.92% to $356.0 million in 2025, then declined by 24.44% to $269.0 million in 2026.
• The last three Current Deferred Revenue figures came in at $269.0 million (Q1 2026), $356.0 million (Q4 2025), and $265.0 million (Q3 2025), per Business Quant data.